Mónika Szepes Selected Research

Poly(ADP-ribose) Polymerase Inhibitors

1/2013

Pretreatment of therapeutic cells with poly(ADP-ribose) polymerase inhibitor enhances their efficacy in an in vitro model of cell-based therapy in myocardial infarct.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Mónika Szepes Research Topics

Disease

3	Ischemia 01/2013 - 11/2011
1	Myocardial Infarction 01/2013
1	Necrosis 01/2013
1	Reperfusion Injury 11/2011

Drug/Important Bio-Agent (IBA)

1	N- (oxo- 5,6- dihydrophenanthridin- 2- yl)- N,N- dimethylacetamide hydrochlorideIBA 01/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2013
1	resazurinIBA 01/2013
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2013
1	Conditioned Culture MediaIBA 01/2013
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2013
1	Glucose (Dextrose)FDA LinkGeneric 11/2011
1	Oxygen (Dioxygen)IBA 11/2011

Therapy/Procedure

1	Therapeutics 01/2013
1	Cell- and Tissue-Based Therapy (Cell Therapy) 11/2011
1	Stem Cell Transplantation 11/2011